Shionogi

Shionogi, a Pharmaceutical Preparation Manufacturing company based in Japan, reported total carbon emissions of approximately 242.2 million kg CO2e in 2024. This figure includes Scope 1 emissions of about 40.09 million kg CO2e, Scope 2 market-based emissions of approximately 22.97 million kg CO2e, and Scope 3 emissions totalling around 179.16 million kg CO2e. Key contributors to Scope 3 emissions were purchased goods and services at approximately 91.37 million kg CO2e and capital goods at roughly 70.06 million kg CO2e.

Looking at historical data, Shionogi's total emissions were approximately 214.94 million kg CO2e in 2023 and about 223.08 million kg CO2e in 2022.

Shionogi has established several climate commitments:

• Near-term targets: Shionogi commits to reducing absolute Scope 1 and 2 GHG emissions by 46.2% by FY2030/31 from a FY2019/20 base year. Additionally, they aim to reduce absolute Scope 3 GHG emissions from purchased goods and services by 20% by FY2030/31 from a FY2019/20 base year. They also aim to reduce Scope 1 and Scope 2 emissions to near zero by the middle of this decade. Further targets include reducing Scope 1 and Scope 2 emissions by 30% from 2020 levels by 2030.
• Long-term targets: Shionogi is committed to achieving net-zero emissions by 2050 across all scopes.

These targets are recognised by the Science Based Targets initiative (SBTi), which classifies their near-term Scope 1 and 2 targets as consistent with reductions required to keep warming to 1.5°C.